Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 416
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III | ||
| NCT00049673 | Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma | ||
| NCT03285841 | OCT-AF Imaging of Pre-cancers of Vulva and Cervix | ||
| NCT00002633 | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | ||
| NCT00036647 | OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00028743 | Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | ||
| NCT00028015 | SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer | ||
| NCT05863910 | Real World Evidence on the Use of Medical Cannabis in Pediatrics | ||
| NCT00255788 | Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer | ||
| NCT01145989 | A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT07341191 | Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy | ||
| NCT02861703 | Pilot Feasibility Study of an Online Lifestyle Intervention for Overweight Breast Cancer Survivors | ||
| NCT05470010 | Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors | ||
| NCT02620735 | Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:Protocol | ||
| NCT02879162 | Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours | ||
| NCT00066586 | Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer | ||
| NCT02414022 | Economic Analysis of Alliance A041202 CLL Study | ||
| NCT03097445 | Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up | ||
| NCT02535754 | Interventions to Increase Workplace Wellness | ||
| NCT03108144 | Personalized Alerts and Care Pathways to Prompt Prevention Interventions for Alcohol and Tobacco Users in Primary Care | ||
| NCT00841607 | Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy | ||
| NCT02619864 | mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme | ||
| NCT00107250 | AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) | ||
| NCT01830621 | BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma | ||
| NCT02740920 | Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker | ||
| NCT04224974 | Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia | ||
| NCT00002678 | Combination Chemotherapy in Treating Patients With Multiple Myeloma | ||
| NCT03938987 | Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | ||
| NCT03917082 | Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | ||
| NCT00066573 | Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer | ||
| NCT01983592 | An N-of-1 Study of Homeopathic Treatment of Fatigue in Patients Receiving Chemotherapy | ||
| NCT00003232 | Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer | ||
| NCT00372736 | AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | ||
| NCT00305812 | Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT01624051 | A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer | ||
| NCT04746859 | Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program | ||
| NCT00005970 | Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer | ||
| NCT00640471 | Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer | ||
| NCT00005957 | Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer | ||
| NCT00438958 | Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases | ||
| NCT01708993 | Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy | ||
| NCT03784755 | Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer | ||
| NCT01248585 | Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases | ||
| NCT01062542 | Assessment of Ovarian Reserve in Female Cancer Survivors | ||
| NCT02628366 | Major Outcomes With Personalized Dialysate TEMPerature | ||
| NCT02125006 | The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain | ||
| NCT01881022 | An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast Cancer | ||
| NCT00036660 | SarCNU in Treating Patients With Recurrent Malignant Glioma | ||
| NCT03847649 | A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies |
